Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 26:76:e3508.
doi: 10.6061/clinics/2021/e3508. eCollection 2021.

Impact of COVID-19 pandemic on the surgical treatment of gastric cancer

Amanda Juliani Arneiro  1 , Marcus Fernando Kodama Pertille Ramos  1 , Marina Alessandra Pereira  1 , André Roncon Dias  1 , Bruno Zilberstein  1 , Ulysses Ribeiro Junior  1 , Sergio Carlos Nahas  1
Affiliations

Impact of COVID-19 pandemic on the surgical treatment of gastric cancer

Amanda Juliani Arneiro et al. Clinics (Sao Paulo). .

Abstract

Objective: The Coronavirus Disease 2019 (COVID-19) pandemic has been recognized as one of the most serious public health crises. This study aimed to evaluate the short-term impact of the pandemic on the surgical treatment of patients with gastric cancer (GC) in addition to their clinicopathological characteristics. We also verified adherence to the COVID-19 screening protocol adopted in the institution.

Methods: All patients with GC who underwent surgical treatment between 2015 and 2021 were retrospectively evaluated and divided into two groups according to the time period: control group (2015-2019) and COVID group (2020-2021). The institutional protocol recommends that patients referred for surgery undergo RT-PCR for severe acute respiratory syndrome coronavirus 2 infection.

Results: A total of 83 patients were classified into the COVID group and 535 into the control group. The number of surgical procedures performed in the control group was 107 (SD±23.8) per year. Diagnostic procedures (p=0.005), preoperative chemotherapy (p<0.001), and adenocarcinomas without Lauren's subtype (p=0.009) were more frequent in the COVID group than in the control group. No significant difference was observed in the pathological characteristics and surgical outcomes of curative GC between the two groups. Evaluation of protocol compliance showed that of 83 patients with GC in the COVID group, 19 (22.9%) were not tested for COVID-19 before surgery. Two patients tested positive for COVID-19 (one preoperative and one postoperative).

Conclusion: A decrease in the average number of surgeries and a higher frequency of diagnostic procedures occurred during the pandemic than in the previous time period. Tumor/node/metastasis classification, morbidity rates, and mortality rates in patients with GC during the pandemic did not differ from those in the previous time period. Accordingly, GC surgical treatment with acceptable screening protocol compliance could be safely performed during the COVID-19 pandemic.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported.

Figures

Figure 1
Figure 1. (A) Total surgical procedures performed between 2005 and 2021. (B) Intention of treatment: curative surgery, palliative surgery, or diagnostic procedures.
Figure 2
Figure 2. Flowchart illustrating the COVID-19 screening protocol employed at the institution.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. - DOI - PMC - PubMed
    1. Al-Jabir A, Kerwan A, Nicola M, Alsafi Z, Khan M, Sohrabi C, et al. Impact of the Coronavirus (COVID-19) pandemic on surgical practice - Part 2 (surgical prioritisation) Int J Surg. 2020;79:233. doi: 10.1016/j.ijsu.2020.05.002. - DOI - PMC - PubMed
    1. Fernandes GA, Feriani D, França E Silva ILA, Mendonça E Silva DR, Arantes PE, Canteras JDS, et al. Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center. Semin Oncol. 2021;48(2):171–80. doi: 10.1053/j.seminoncol.2021.01.003. - DOI - PMC - PubMed
    1. Apostolou K, Vogli S, Frountzas M, Syllaios A, Tolia M, Papanikolaou IS, et al. Upper Gastrointestinal Cancer Management in the COVID-19 Era: Risk of Infection, Adapted Role of Endoscopy, and Potential Treatment Algorithm Alterations. J Gastrointest Cancer. 2021;52(2):407–13. doi: 10.1007/s12029-020-00557-y. - DOI - PMC - PubMed
    1. Sobrado LF, Nahas CSR, Marques CFS, Cotti GCC, Imperiale AR, Averbach P, et al. Is it Safe to Perform Elective Colorectal Surgical Procedures during the COVID-19 Pandemic? A Single Institution Experience with 103 Patients. Clinics (Sao Paulo) 2021;76:e2507. doi: 10.6061/clinics/2021/e2507. - DOI - PMC - PubMed